MX2024004570A - Tabletas de dextrosa de multiples capas. - Google Patents
Tabletas de dextrosa de multiples capas.Info
- Publication number
- MX2024004570A MX2024004570A MX2024004570A MX2024004570A MX2024004570A MX 2024004570 A MX2024004570 A MX 2024004570A MX 2024004570 A MX2024004570 A MX 2024004570A MX 2024004570 A MX2024004570 A MX 2024004570A MX 2024004570 A MX2024004570 A MX 2024004570A
- Authority
- MX
- Mexico
- Prior art keywords
- layered
- dextrose
- tablet
- tablets
- dextrose tablets
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Pain & Pain Management (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17/502,322 US20230123099A1 (en) | 2021-10-15 | 2021-10-15 | Dextrose tablets with improved mouthfeel |
| PCT/DK2022/050215 WO2023061544A1 (en) | 2021-10-15 | 2022-10-12 | Multi-layered dextrose tablets |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024004570A true MX2024004570A (es) | 2024-04-30 |
Family
ID=84047794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024004570A MX2024004570A (es) | 2021-10-15 | 2022-10-12 | Tabletas de dextrosa de multiples capas. |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20230123099A1 (https=) |
| EP (2) | EP4415687A1 (https=) |
| JP (2) | JP2024538788A (https=) |
| KR (1) | KR20240072292A (https=) |
| CN (2) | CN118103028A (https=) |
| AU (2) | AU2022367650B2 (https=) |
| CA (2) | CA3175564A1 (https=) |
| MX (1) | MX2024004570A (https=) |
| WO (2) | WO2023061543A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK202430540A1 (en) * | 2024-09-12 | 2026-03-26 | Fertin Pharma As | Orally disintegrating nicotine tablet with reduced sweetener content |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6270790B1 (en) * | 1998-08-18 | 2001-08-07 | Mxneil-Ppc, Inc. | Soft, convex shaped chewable tablets having reduced friability |
| AU1031500A (en) | 1998-11-03 | 2000-05-22 | Dandy A/S | Sucrose fatty acid esters for use as increased release of active ingredients |
| US20020122823A1 (en) * | 2000-12-29 | 2002-09-05 | Bunick Frank J. | Soft tablet containing dextrose monohydrate |
| EP1660104B1 (en) * | 2003-08-26 | 2010-03-10 | Shire Holdings AG | Pharmaceutical formulation comprising lanthanum compounds |
| US8758814B2 (en) * | 2004-10-08 | 2014-06-24 | Mcneil-Ppc, Inc. | Chewable enteric coated aspirin tablets |
| EP2178522A1 (en) * | 2007-07-11 | 2010-04-28 | Fertin Pharma A/S | Compressed chewing gum tablet comprising taste-masking agent |
| CN101772304B (zh) * | 2007-07-31 | 2014-07-09 | 卡吉尔公司 | 直接可压缩的右旋糖 |
| EP2395972A4 (en) * | 2009-02-11 | 2014-02-12 | Liangping Yu | PARTICULATE COMPOSITION AND METHOD FOR PRODUCING THE SAME |
| US20100247586A1 (en) * | 2009-03-27 | 2010-09-30 | Andreas Hugerth | Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties |
| CN101856121B (zh) * | 2010-05-19 | 2012-05-23 | 北京联合大学生物化学工程学院 | 一种咀嚼片及其制备方法 |
| CN107028900A (zh) * | 2010-12-02 | 2017-08-11 | 艾戴尔医药公司 | 快速分散颗粒、口腔崩解片以及方法 |
| US10632076B2 (en) * | 2016-11-18 | 2020-04-28 | Fertin Pharma A/S | Tablet comprising separate binder and erythritol |
| KR102037205B1 (ko) * | 2018-02-14 | 2019-10-28 | 경기도 양평군(양평군 농업기술센터장) | 밀크씨슬과 흰꽃무지 굼벵이를 이용한 기능성 식품의 제조방법 |
-
2021
- 2021-10-15 US US17/502,322 patent/US20230123099A1/en active Pending
-
2022
- 2022-09-20 CA CA3175564A patent/CA3175564A1/en active Pending
- 2022-10-12 KR KR1020247015902A patent/KR20240072292A/ko active Pending
- 2022-10-12 CA CA3232753A patent/CA3232753A1/en active Pending
- 2022-10-12 MX MX2024004570A patent/MX2024004570A/es unknown
- 2022-10-12 WO PCT/DK2022/050214 patent/WO2023061543A1/en not_active Ceased
- 2022-10-12 CN CN202280068610.8A patent/CN118103028A/zh active Pending
- 2022-10-12 US US18/686,557 patent/US20240415775A1/en active Pending
- 2022-10-12 WO PCT/DK2022/050215 patent/WO2023061544A1/en not_active Ceased
- 2022-10-12 AU AU2022367650A patent/AU2022367650B2/en active Active
- 2022-10-12 AU AU2022363912A patent/AU2022363912B2/en active Active
- 2022-10-12 EP EP22800585.6A patent/EP4415687A1/en active Pending
- 2022-10-12 EP EP22800584.9A patent/EP4415686A1/en active Pending
- 2022-10-12 JP JP2024522357A patent/JP2024538788A/ja active Pending
- 2022-10-12 CN CN202280068612.7A patent/CN118103029A/zh active Pending
- 2022-10-12 JP JP2024522359A patent/JP2024538789A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4415686A1 (en) | 2024-08-21 |
| AU2022363912B2 (en) | 2025-10-30 |
| WO2023061543A1 (en) | 2023-04-20 |
| CN118103029A (zh) | 2024-05-28 |
| KR20240072292A (ko) | 2024-05-23 |
| EP4415687A1 (en) | 2024-08-21 |
| CA3175564A1 (en) | 2023-04-15 |
| US20240415775A1 (en) | 2024-12-19 |
| AU2022367650A1 (en) | 2024-03-14 |
| AU2022363912A1 (en) | 2024-03-14 |
| JP2024538789A (ja) | 2024-10-23 |
| CN118103028A (zh) | 2024-05-28 |
| WO2023061544A1 (en) | 2023-04-20 |
| AU2022367650B2 (en) | 2025-10-23 |
| JP2024538788A (ja) | 2024-10-23 |
| CA3232753A1 (en) | 2023-04-20 |
| US20230123099A1 (en) | 2023-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP088490A (es) | Forma farmacéutica oral que contiene como principios activos un inhibidor de la bomba de protones junto con ácido acetilsalicílico | |
| GT200600295A (es) | Una formulacion solida de dosificacion farmaceutica | |
| AR038527A1 (es) | Forma de dosificacion que contiene un inhibidor de la pde 4 como ingrediente activo | |
| CO2020008825A2 (es) | Regímenes de dosificación superior de g1t38 | |
| ME02189B (me) | Farmaceutski dozni oblici sa kontrolisanim oslobađanjem | |
| PE20030580A1 (es) | Composiciones farmaceuticas de glibenclamida y metformina, en capas separadas | |
| AR058604A1 (es) | Comprimido multicapa con combinacion de triple liberacion | |
| AR062721A1 (es) | Composicion farmaceutica de liberacion modificada para administracion oral que comprende una pluralidad de mini- comprimidos con un inhibidor del factor xa, su uso para prpeparar un medicamento y proceso para prepararla | |
| MX2024004570A (es) | Tabletas de dextrosa de multiples capas. | |
| MX2021012712A (es) | Tabletas de cannabinoides de desintegracion rapida. | |
| CO2021013251A2 (es) | Derivados de insulina sensibles a la glucosa | |
| AR033748A1 (es) | Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo | |
| PA8809601A1 (es) | Combinación anti-retroviral | |
| CY1110097T1 (el) | Διπλοστοιβαδικο δισκιο για προληψη καρδιαγγειακων συμβαντων | |
| CO2024002256A2 (es) | Formas de dosificación gastrorretentivas de 5-hidroxitriptófano | |
| MX2020007322A (es) | Indicador biologico. | |
| MX2023012535A (es) | Composicion oral efervescente. | |
| CO6321223A2 (es) | Formulacion farmaceutica solida que contiene ciclostazol | |
| AR114418A1 (es) | Compuesto cíclico de metilactama y su utilización farmacéutica | |
| CO2024002748A2 (es) | Profármaco de derivados de pirrolidona como activador de glucocinasa | |
| CO5640087A2 (es) | Composiciones de farmacos anti-inflamatorios no esteroideos descongestionantes y anti-histaminicos | |
| AR115913A1 (es) | Formas de dosificación oral biodisponibles, uso, métodos | |
| MX2009010738A (es) | Dentifrico con capas de envasado. | |
| CO2022018623A2 (es) | Composiciones farmacéuticas que contienen sustancias liberadoras de enterocinas en múltiples formas de dosificación combinadas con agentes gelificantes | |
| AR057932A1 (es) | Comprimido bicapa que comprende telmisartan y diuretico |